# Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects

> **NCT02016560** · PHASE2,PHASE3 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 383 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** florbetapir F 18
- **DRUG:** Flortaucipir F18
- **PROCEDURE:** Brain PET Scan

## Key facts

- **NCT ID:** NCT02016560
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2017-07-28
- **Final completion:** 2017-07-28
- **Target enrollment:** 383 (ACTUAL)
- **Last updated:** 2020-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02016560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02016560, "Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02016560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*